Case Study
Global biosimilars company halves data transcription errors and connects >350 instruments & systems with IDBS Polar
Global biosimilars company halves data transcription errors and connects >350 instruments & systems with IDBS Polar
A global biosimilars company partnered with IDBS to advance its long-term digital transformation strategy and improve laboratory data management across the biopharmaceutical lifecycle. Before digitization, researchers spent significant time printing, archiving, and manually transcribing laboratory records, creating inefficiencies, increasing paper storage requirements, and raising the risk of data entry errors. To address these challenges, the company implemented IDBS Polar to connect more than 350 laboratory instruments and systems, enabling automated data capture and streamlined workflows. The solution reduced manual processes, improved data accuracy, and cut transcription errors by 50%, while enhancing traceability, compliance, and operational efficiency. By integrating laboratory data
